Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/19/2026

1. KLAR
2. KEYS
3. EPM
4. PANW
5. DVLT
6. HD
7. MRCY
8. EL
9. NAPD
10. LOW

Go back to Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment
(NASDAQ: ELTX) Delayed: 3.11 --0 (-0%)
Previous Close $3.11    52 Week High $ 
Open $3.11    52 Week Low $ 
Day High $3.11    P/E N/A 
Day Low $3.11    EPS $ 
Volume 5,485